tiprankstipranks
Trending News
More News >
BillionToOne, Inc. Class A (BLLN)
NASDAQ:BLLN
US Market

BillionToOne, Inc. Class A (BLLN) Earnings Dates, Call Summary & Reports

Compare
17 Followers

Earnings Data

Report Date
Dec 09, 2025
After Close (Confirmed)
Period Ending
Consensus EPS Forecast
Last Year’s EPS
Same Quarter Last Year
Moderate Buy
Based on 7 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Dec 09, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
BillionToOne's first earnings call as a public company highlighted strong revenue growth, successful IPO, and robust gross margins. Despite challenges such as negative mix shifts and the need for further investment in EMR, the company's significant achievements and strong market position reflect a positive outlook.
Company Guidance
During the BillionToOne third-quarter 2025 earnings call, the company provided extensive guidance and highlighted significant financial metrics. BillionToOne reported a remarkable year-over-year revenue growth of 117%, reaching $83.5 million in the third quarter. This growth was driven by a 51% increase in test volumes and expanding average selling prices (ASPs) across all products. Gross margins improved substantially to 70%, up from 53% the previous year, due to increased ASPs and reduced cost per test. The company achieved a positive GAAP operating margin of 11.5%, marking its first quarter of positive GAAP operating income. Guidance for the full year 2025 projects total revenue between $293 million and $299 million, reflecting a growth rate of 92% to 96% compared to 2024. BillionToOne outlined plans for continued investment in its sales force and electronic medical records (EMR) integration, which is expected to enhance market adoption. The company also highlighted its goal to maintain profitability while focusing on expanding its oncology products and achieving significant milestones in MRD (minimal residual disease) testing by the end of 2026.
Successful IPO and Strong Capital Position
Completed an initial public offering on NASDAQ, raising $314 million in gross proceeds, positioning the company for future growth with a strong balance sheet.
Impressive Revenue and Growth Metrics
Achieved $83.5 million in Q3 2025 revenue, a 117% increase from Q3 2024, and a 51% increase in test growth with 163,000 tests. Annualized revenue run rate reached $334 million.
Strong Gross Margin Expansion
Achieved a gross margin of 70% in Q3 2025, a 17 percentage point increase from the previous year, driven by ASP growth and cost reductions.
Positive GAAP Operating Margin
Reported an 11.5% positive GAAP operating margin, with the expectation to maintain positive GAAP operating income moving forward.
Significant Growth in Oncology Segment
Oncology revenues grew by 664% to $8.7 million in Q3 2025 compared to the same period last year.
Key Partnerships and Publications
Finalized an exclusive agreement with Johnson & Johnson and published studies validating the company's technology in prenatal and oncology settings.

BillionToOne, Inc. Class A (BLLN) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

BLLN Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Dec 09, 2025
2025 (Q3)
0.14 / 0.10
-0.333130.03% (+0.43)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

FAQ

When does BillionToOne, Inc. Class A (BLLN) report earnings?
BillionToOne, Inc. Class A (BLLN) is schdueled to report earning on Dec 09, 2025, After Close (Confirmed).
    What is BillionToOne, Inc. Class A (BLLN) earnings time?
    BillionToOne, Inc. Class A (BLLN) earnings time is at Dec 09, 2025, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is BLLN EPS forecast?
          Currently, no data Available